Sechenov School
Home › Pharmacology › Centrally Acting Antihypertensive Drugs

Centrally Acting Antihypertensive Drugs

Medamenta antihypertensiva centraliter agentia

For medical students2 min readUpdated 2026-10-10

Centrally acting antihypertensive drugs lower blood pressure by reducing sympathetic outflow to the heart and blood vessels. They act on structures within the medulla oblongata, decreasing cardiac output and total peripheral resistance.

Localizationmedulla oblongata, nucleus tractus solitarii
ReceptorsI1-imidazoline and alpha2-adrenergic receptors
Drugsmoxonidine, clonidine, methyldopa, guanfacine
Hemodynamicsdecreased cardiac output and total peripheral resistance (TPR)

Anatomical Substrate and Localization of Action

The primary level of central regulation of vascular tone is the medulla oblongata. Its rostral and ventrolateral regions contain the vasomotor center, which includes the C-1 vasoconstrictor area and the cardioacceleratory area. The key sensory structure here is the nucleus tractus solitarii (nucleus of the solitary tract).

This nucleus processes incoming signals of two types:

  1. Descending impulses from higher CNS centers (cerebral cortex and hypothalamus).
  2. Afferent signals from carotid sinus and aortic arch baroreceptors, transmitted via the vagus nerve.

Membranes of the neurons in the nucleus of the solitary tract harbor two key molecular targets: I1-imidazoline receptors (whose endogenous ligand is agmatine) and alpha2-adrenergic receptors.

Mechanism of Action and Pharmacological Differences

Centrally acting drugs stimulate neurons in the nucleus of the solitary tract, initiating an inhibitory cascade directed at the vasomotor center via interneurons. However, their receptor interaction profiles differ:

Efferent Pathways and Systemic Effects

Activation of receptors in the nucleus of the solitary tract shifts the autonomic balance through two main pathways:

  1. Suppression of sympathetic activity: Inhibitory interneurons suppress the vasomotor center. Consequently, descending adrenergic outflow decreases to the blood vessels (reducing total peripheral resistance), to the heart (decreasing heart rate and contractility, thereby lowering cardiac output), and to the kidneys (reducing renin secretion).
  2. Activation of parasympathetic activity: The nucleus of the solitary tract stimulates the dorsal motor nucleus of the vagus nerve (n. vagus), enhancing cholinergic tone to the heart and causing bradycardia.

A typical adverse effect accompanying the drop in blood pressure is fluid retention, acting as a compensatory renal response.

Mnemonic

"Methyldopa mimics a metabolite (alpha-methylnorepinephrine), while moxonidine makes a beeline for I1."

Frequently asked questions

What are the absolute and relative contraindications for centrally acting antihypertensive drugs?

Available sources highlight specific restrictions for individual agents within this class:

  • Clonidine and guanfacine — driving or operating machinery is contraindicated during their use because they cause drowsiness, lethargy, and slowed reaction times.
  • Methyldopa — not recommended during the postpartum period due to an increased risk of postpartum depression.

General absolute contraindications for the entire drug class are not specified here.

What is the primary anatomical center responsible for the action of these drugs?

The main anatomical substrate is the medulla oblongata, specifically the nucleus of the solitary tract (nucleus tractus solitarii), where the target receptors are localized.

What is the pharmacodynamic peculiarity of methyldopa?

Methyldopa is a prodrug. In the body, it is converted into the active metabolite alpha-methylnorepinephrine, which selectively stimulates alpha2-adrenergic receptors.

Which hemodynamic parameters are reduced under the influence of these agents?

The reduction in sympathetic outflow leads to a simultaneous decrease in two main parameters: cardiac output and total peripheral resistance (TPR).

Go deeper

More topics in Pharmacology

Erythropoietin AgentsIndobufenLipoproteinsAntitussivesEmeticsOrganic NitratesMechanisms of Arrhythmias and Principles of TherapyPolyene AntibioticsStages of General AnesthesiaCardiomyocyte Contraction MechanismHalogens and Halogen-Containing CompoundsTolbutamidePharmacology →